Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Total Liabilities (2023 - 2026)

Camp4 Therapeutics' Total Liabilities history spans 3 years, with the latest figure at $70.1 million for Q4 2025.

  • On a quarterly basis, Total Liabilities rose 362.34% to $70.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $70.1 million, a 362.34% increase, with the full-year FY2025 number at $70.1 million, up 362.34% from a year prior.
  • Total Liabilities hit $70.1 million in Q4 2025 for Camp4 Therapeutics, up from $27.7 million in the prior quarter.
  • Over the last five years, Total Liabilities for CAMP hit a ceiling of $147.1 million in Q2 2024 and a floor of $11.2 million in Q1 2025.
  • Historically, Total Liabilities has averaged $56.4 million across 3 years, with a median of $23.0 million in 2024.
  • The widest YoY moves for Total Liabilities: up 362.34% in 2025, down 92.33% in 2025.
  • Tracing CAMP's Total Liabilities over 3 years: stood at $16.5 million in 2023, then dropped by 8.26% to $15.2 million in 2024, then skyrocketed by 362.34% to $70.1 million in 2025.
  • Business Quant data shows Total Liabilities for CAMP at $70.1 million in Q4 2025, $27.7 million in Q3 2025, and $11.3 million in Q2 2025.